| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 03/27/2013 | EP2571871A1 Process for the preparation of chiral triazolones |
| 03/27/2013 | EP2571870A1 Ccr2 antagonists and uses thereof |
| 03/27/2013 | EP2571869A1 Purification of posaconazole and posaconazole intermediates |
| 03/27/2013 | EP2571868A1 Preparation of posaconazole intermediates |
| 03/27/2013 | EP2571865A1 2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl-sulfonamide derivatives |
| 03/27/2013 | EP2571853A1 Inhibitors of human 12-lipoxygenase |
| 03/27/2013 | EP2571847A1 Process for the preparation of chiral hydrazides |
| 03/27/2013 | EP2571352A1 Selective hdac inhibitors |
| 03/27/2013 | CN1972916B 肉桂酰胺类化合物 Cinnamic amides |
| 03/27/2013 | CN103003239A Spiroheterocyclic pyrrolidine derivatives based pesticides |
| 03/27/2013 | CN102993186A Novel piperazine derivative |
| 03/27/2013 | CN102993148A Quercetin derivatives or analogs thereof, and application thereof |
| 03/27/2013 | CN102993102A Synthetic method of [1-methyl-2-(8'-octyl hydroxamic acid group)-5-N,N-bi(2'-chloroethyl)]-1H-benzimidazole |
| 03/27/2013 | CN102993097A Pyrazole amide compound and application thereof |
| 03/27/2013 | CN102267971B Alicyclic-o[c] benzopyrone derivative and application thereof |
| 03/27/2013 | CN102036955B Hydroxamate-based inhibitors of deacetylases b |
| 03/27/2013 | CN102010281B Preparation method of alpha-acyloxy ether |
| 03/27/2013 | CN101903340B Substituted N-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 03/27/2013 | CN101146786B Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 03/27/2013 | CN101137623B N-sulphonylpyrroles and use thereof as histone deacetylase inhibitors |
| 03/27/2013 | CN101072503B 3-cyclopropyl-4-(3-amino-2-methylbenzoyl)pyrazols and the use of the same as herbicides |
| 03/26/2013 | US8404855 Substituted enaminocarbonyl compounds |
| 03/26/2013 | US8404852 Gyrase inhibitors and uses thereof |
| 03/26/2013 | US8404698 Quinazoline derivatives and therapeutic use thereof |
| 03/26/2013 | US8404690 Piperazine-2-carboxamide derivatives |
| 03/26/2013 | US8404681 Xanthones, thioxanthones and acridinones as DNA-PK inhibitors |
| 03/26/2013 | US8404679 Pyrrolidine derivatives as NK2 receptor antagonists |
| 03/21/2013 | WO2013040044A1 Aminopyrimidine derivatives for use as modulators of kinase activity |
| 03/21/2013 | WO2013039202A1 Novel acrylic acid derivative |
| 03/21/2013 | WO2013039073A1 Aromatic amine derivative and organic electroluminescence element using same |
| 03/21/2013 | WO2013038843A1 Organic electroluminescent element |
| 03/21/2013 | WO2013038804A1 Organic electroluminescent element |
| 03/21/2013 | WO2013037942A1 Synthesis of triazolopyrimidine compounds |
| 03/21/2013 | WO2013037894A1 Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group |
| 03/21/2013 | WO2013037755A1 Plant growth regulating compounds |
| 03/21/2013 | WO2013037703A1 3 -pyridine carboxylic acid hydrazides as hdl-cholesterol raising agents |
| 03/21/2013 | US20130072688 Method for preparing an intermediate of pitavastatin or of the salt thereof |
| 03/21/2013 | US20130072683 Epoxy compound and method for manufacturing the same |
| 03/21/2013 | US20130072679 Dihydroquinoline-2-one derivatives |
| 03/21/2013 | US20130072530 Novel ep4 agonist |
| 03/21/2013 | US20130072523 Analogues for the treatment or prevention of flavivirus infections |
| 03/21/2013 | US20130072487 Prolyl hydroxylase inhibitors |
| 03/21/2013 | US20130072461 Triazole compounds that modulate hsp90 activity |
| 03/21/2013 | US20130072457 Pyrazolyl quinazoline kinase inhibitors |
| 03/21/2013 | CA2848621A1 Synthesis of triazolopyrimidine compounds |
| 03/21/2013 | CA2848615A1 Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group |
| 03/21/2013 | CA2846779A1 Plant growth regulating compounds |
| 03/21/2013 | CA2844865A1 3-pyridine carboxylic acid hydrazides as hdl-cholesterol raising agents |
| 03/21/2013 | CA2844704A1 Aminopyrimidine derivatives for use as modulators of kinase activity |
| 03/20/2013 | EP2570405A1 Synthesis of Triazolopyrimidine Compounds |
| 03/20/2013 | EP2569302A1 Heteroaryloxyheterocyclyl compounds as pde10 inhibitors |
| 03/20/2013 | EP2569299A1 Nitrogen- heterocyclic compounds as phosphodiesterase 10 inhibitors |
| 03/20/2013 | EP2569298A1 Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments |
| 03/20/2013 | EP2569297A1 Substituted n-heterocycloalkyl bipyrrolidinylphenyl amide derivatives, preparation and therapeutic use thereof |
| 03/20/2013 | EP2569295A1 New ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments |
| 03/20/2013 | EP2569280A1 Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof |
| 03/20/2013 | CN1606554B Beta-lactamyl vasopressin v1a antagonists |
| 03/20/2013 | CN1302801B Substituted aminoquinazolone (thio-ketone) derivative or its salt, its intermediate and pest controlling agent and its application method |
| 03/20/2013 | CN102985417A Piperidin-4-yl azetidine derivatives as JAK1 inhibitors |
| 03/20/2013 | CN102985405A Heterocyclic compound, and p27 kip1 degradation inhibitor |
| 03/20/2013 | CN102977083A New crystal form XVII of 1-(4-(5-cyanoindole-3-yl) butyl)-4-(2-carbamyl-benzofuran-5-yl)-piperazine hydrochloride and preparation method of new crystal form XVII |
| 03/20/2013 | CN102977082A Isocoumarin compound as well as preparation method and application thereof |
| 03/20/2013 | CN102977081A Homopiperony lamine pyridine -2- formaldehyde and synthetic method and application thereof |
| 03/20/2013 | CN102977080A Photochromic materials with reactive substituents |
| 03/20/2013 | CN102977029A 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto |
| 03/20/2013 | CN102977028A Fungicide N-cycloalkyl-N-bicyclic-carboxamide derivatives |
| 03/20/2013 | CN102101852B Coumarin derivates, preparation method thereof and application thereof in white-light organic electroluminescent device |
| 03/20/2013 | CN101962380B Novel organic conjugated molecule and application thereof in organic solar cell |
| 03/20/2013 | CN101466709B 1,5 and 3,6- substituted indole compounds having NOS inhibitory activity |
| 03/20/2013 | CN101039920B 2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists |
| 03/19/2013 | US8399673 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators |
| 03/19/2013 | US8399493 Pyridinone derivatives and their use as positive allosteric modulators of mGluR2-receptors |
| 03/19/2013 | US8399482 6-substituted isoquinolines and isoquinolinones |
| 03/19/2013 | CA2549228C Hiv protease inhibiting compounds |
| 03/14/2013 | WO2013036866A1 Itraconazole analogs and use thereof |
| 03/14/2013 | WO2013036224A1 Use of 1h-quinazoline- 2, 4 -diones for use in the prevention or treatment photosensitive epilepsy |
| 03/14/2013 | WO2013036207A1 Derivatives of xanthone compounds |
| 03/14/2013 | WO2013035827A1 Novel olefin derivative |
| 03/14/2013 | WO2013035754A1 Method for producing coumarin derivative |
| 03/14/2013 | WO2013035275A1 Nitrogen-containing heteroaromatic ring compound |
| 03/14/2013 | WO2013034238A1 Benzonitrile derivatives as kinase inhibitors |
| 03/14/2013 | WO2013034048A1 Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases |
| 03/14/2013 | WO2013034047A1 Heterocyclic-substitued benzofuran derivatives and methods of use thereof for the treatment of viral diseases |
| 03/14/2013 | WO2013033971A1 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases |
| 03/14/2013 | WO2013033899A1 Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases |
| 03/14/2013 | US20130066252 Method for diagnosis for multiple sclerosis involving anti1-receptor antibody |
| 03/14/2013 | US20130066083 Processes and intermediates |
| 03/14/2013 | US20130066081 Imidazolone-chalcone derivatives as potential anticancer agent and process for the preparation thereof |
| 03/14/2013 | US20130065923 Substituted n-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof |
| 03/14/2013 | US20130065919 Substituted n-alkyl and n-acyl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof |
| 03/14/2013 | US20130065918 Soluble guanylate cyclase activators |
| 03/14/2013 | US20130065905 Nitrogen-containing heterocyclic compound having inhibitory effect on production of kynurenine |
| 03/14/2013 | US20130065900 Pharmaceutical compounds |
| 03/14/2013 | US20130065897 Compounds, preparation and uses thereof |
| 03/14/2013 | US20130065896 Fused imidazole derivative |
| 03/14/2013 | US20130065882 VLA-4 inhibitory drug |
| 03/14/2013 | US20130065880 Compounds as tyrosine kinase modulators |
| 03/14/2013 | US20130065877 Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof |
| 03/14/2013 | US20130065876 3-pyridine carboxylic acid hydrazides |
| 03/14/2013 | US20130065056 Photochromic materials having extended pi-conjugated systems and compositions and articles including the same |